Descripción:
General description ArthritisHeal
The ArthritisHeal project aims to train young researchers to generate novel therapeutic targets focusing on the role of pro-resolving lipids in two rheumatic diseases; osteoarthritis (OA) and rheumatoid arthritis (RA). The network is composed of 7 universities and 2 companies that will train 12 ESRs. In addition, 8 associated partners will provide secondment opportunities and training in topics such as regulatory and IP issues, presentation skills and career development. The beneficiaries combine expertise in clinical sciences, pre-clinical RA and OA models, biochemistry and data analysis. Each ESR will follow a personalized training programme covering all aspects of development of novel therapeutic targets, from discovery to validation in patients.
ESR11 Pharmacometabolomic study of osteoarthritis and rheumatoidArthritis using MS and NMR spectroscopy (PG)
We seek a highly motivated PhD-student who will apply metabolomic methods to human rheumatoid Arthritis cohorts and animal models, to define molecular diagnostic markers associated to therapy response, as well as therapy related side effects. The PhD-student will plan and undertake the experiments, and will report and publish the results in scientific journals and at international conferences. The student will also perform metabolites analysis in specific in vitro cell culture experiments, aiming to address resolution mechanisms (in close collaboration with Leiden University Medical Center (LUMC), Leiden, The Netherlands and Eberhard Karls University Tübingen (EKU), Germany. Analysis of biologically relevant sample materials will allow the student to acquire a solid knowledge in NMR and MS based metabolomics analytical chemistry, biochemistry and biology with a special focus on arthritis,
The Company and the University
PharmaGnose S.A. is a spin off company of the University of Athens supplier of R&D solutions in terms of products and services (http://pharmagnose.com/). PharmaGnose is service provider for development and validation of analytical methods using state of the art analytical techniques, profiling and fingerprinting, pharmacokinetic studies, LCMS and NMR based metabolomics in human biofluids and plant extracts supervised by Prof E, Mikros (http://biospec.pharm.uoa.gr/). The student will be enrolled in the School of Medicine National Kapodistrian University of Athens and collaborate for sample collection with the Department of Pathophysiology fully equipped with cell culture, molecular biology, histology, flow cytometry and autoantibodies analysis facilities, and of a 45-bed clinic as well as daily and outpatient clinics, under the guidance of professor A. Tzioufas.
Your profile
We are seeking a highly motivated researcher with an MSc degree in biomedical sciences or chemistry, preferably with expertise in analytical chemistry. Applicants experienced in NMR and/or MS will be prioritized. Experience with cell biology would be helpful. English language skills are essential for communication within the team and the consortium, but also for scientific presentations and publications. PhD-students involved in this project will make short-term exchange visits in LUMC and EKU. Training in multivariate statistics will be provided as part of our PhD training.
Application procedure:
Application in English includes:
- Motivation letter
- CV
- Official academic transcript of Bsc and Msc studies
- Documentation of English language qualifications
- Full contact details of two reference persons
Please send your full application with e-mail to info@pharmagnose.com, subject: ArthritisHeal Vacancy ESR11
What we offer
You will be employed on the basis of a 40-hour week. Appointment is for a maximum of four years, to be completed with a doctoral thesis. Your salary is around € 34,000 per year.
More information
For more information and details about the project, please go to the ArthritisHeal website (www.ArthritisHeal.eu). If you have any questions or would like more information about this vacancy, please contact Prof Emmanuel Mikros, Pharmagnose (info@pharmagnose.com)